Avanos Medical Valuation
| AVNS Stock | USD 19.15 0.34 1.74% |
At this time, the firm appears to be undervalued. Avanos Medical shows a prevailing Real Value of $20.41 per share. The current price of the firm is $19.15. Our model approximates the value of Avanos Medical from analyzing the firm fundamentals such as return on equity of 0.0177, and Profit Margin of 0.02 % as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Avanos Medical's price fluctuation is not too volatile at this time. Calculation of the real value of Avanos Medical is based on 3 months time horizon. Increasing Avanos Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Avanos stock is determined by what a typical buyer is willing to pay for full or partial control of Avanos Medical. Since Avanos Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Avanos Stock. However, Avanos Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 19.15 | Real 20.41 | Hype 19.2 |
The intrinsic value of Avanos Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Avanos Medical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Avanos Medical helps investors to forecast how Avanos stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Avanos Medical more accurately as focusing exclusively on Avanos Medical's fundamentals will not take into account other important factors: Avanos Medical Total Value Analysis
Avanos Medical is presently estimated to have valuation of 1.01 B with market capitalization of 895.7 M, debt of 209.1 M, and cash on hands of 106.5 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Avanos Medical fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.01 B | 895.7 M | 209.1 M | 106.5 M |
Avanos Medical Investor Information
About 94.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.73. Some equities with similar Price to Book (P/B) outperform the market in the long run. Avanos Medical has Price/Earnings To Growth (PEG) ratio of 2.29. The entity had not issued any dividends in recent years. Based on the analysis of Avanos Medical's profitability, liquidity, and operating efficiency, Avanos Medical is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Avanos Medical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Avanos Medical has an asset utilization ratio of 39.78 percent. This implies that the Company is making $0.4 for each dollar of assets. An increasing asset utilization means that Avanos Medical is more efficient with each dollar of assets it utilizes for everyday operations.Avanos Medical Ownership Allocation
Avanos Medical holds a total of 45.96 Million outstanding shares. The majority of Avanos Medical outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Avanos Medical to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Avanos Medical. Please pay attention to any change in the institutional holdings of Avanos Medical as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Avanos Medical Profitability Analysis
The company reported the previous year's revenue of 673.3 M. Net Loss for the year was (9.9 M) with profit before overhead, payroll, taxes, and interest of 450 M.About Avanos Medical Valuation
The stock valuation mechanism determines Avanos Medical's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Avanos Medical based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Avanos Medical. We calculate exposure to Avanos Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Avanos Medical's related companies.Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia. Avanos Medical operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 4555 people.
Avanos Medical Growth Indicators
Investing in growth stocks can be very risky. If the company such as Avanos Medical does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 46.6 M | |
| Quarterly Earnings Growth Y O Y | -0.375 |
Additional Tools for Avanos Stock Analysis
When running Avanos Medical's price analysis, check to measure Avanos Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avanos Medical is operating at the current time. Most of Avanos Medical's value examination focuses on studying past and present price action to predict the probability of Avanos Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avanos Medical's price. Additionally, you may evaluate how the addition of Avanos Medical to your portfolios can decrease your overall portfolio volatility.